Innovations in Human and Companion Animal Health
ProteaPex Therapeutics’ patented, platform technology of locally-delivered therapeutics
ProteaPex Therapeutics is developing an innovative disease modifying therapeutic to treat various conditions in humans and companion animals. This new class of therapeutic, the Extracellular Matrix Protection Factor (ECPF), is a safe and effective peptide for human and animal health.
This new class of therapeutic, the Extracellular Matrix Protection Factor, is a safe and effective intra-joint injection that reduces the pain and damage caused by osteoarthritis.